The Gal-3 presentation has been documented in a variety of cardiac and noncardiac conditions in companies with AF, such as coronary artery and other heart diseases, metabolic syndrome, diabetes, chronic renal failure, as well as ischemic stroke. The gene discussed is LGALS3; the disease is diabetes mellitus.